Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Clasificación en acciones #41417
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Precio por acción
$0.0001
Última sincronización: 2025-06-11
Capitalización bursátil
$21.52K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio Diagnocure, Inc. (DGCRF)

Categoría

Precio DGCRF con Capital del mercado a B
Diagnocure, Inc. Diagnocure, Inc.
DGCRF
$0.0001
Capitalización de mercado de Diagnocure, Inc.(DGCRF)
Capitalización bursátil: $21.52K
A fecha de August 2026, Diagnocure, Inc. tiene una capitalización de mercado de $21.52K. Esto convierte a Diagnocure, Inc. en la 41417th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Diagnocure, Inc. desde 2012 hasta 2026
DGCRF en comparación con los más populares 5 títulos stocks
Precio por DGCRF Activo B Capital del mercado en B Resultados
Diagnocure, Inc. Diagnocure, Inc.
$25,289.11 $21.52K
$5.442T +25,289,110,258.42%
Diagnocure, Inc. Diagnocure, Inc.
$20,740.09 $21.52K
$4.463T +20,740,089,683.88%
Diagnocure, Inc. Diagnocure, Inc.
$19,355.41 $21.52K
$4.165T +19,355,410,864.57%
Diagnocure, Inc. Diagnocure, Inc.
$17,098.26 $21.52K
$3.680T +17,098,260,208.68%
Diagnocure, Inc. Diagnocure, Inc.
$13,332.16 $21.52K
$2.869T +13,332,155,509.23%